CLOSE×

    Oncology

    Ruban, A., Berkutzki, T., Cooper, I., Mohar, B., & Teichberg, V. I. (2012).,Blood glutamate scavengers prolong the survival of rats and mice with brain-implanted gliomas., Investigational New Drugs, 30(6), 2226-2235. doi:10.1007/s10637-012-9799-5 [doi]
    Lev-Ari, S., Starr, A., Katzburg, S., Berkovich, L., Rimmon, A., Ben-Yosef, R., . . . Earon, G. (2014).,Curcumin induces apoptosis and inhibits growth of orthotopic human non-small cell lung cancer xenografts., The Journal of Nutritional Biochemistry, 25(8), 843-850. doi:10.1016/j.jnutbio.2014.03.014 [doi]
    Carosio, R., Pistoia, V., Orienti, I., Formelli, F., Cavadini, E., Mangraviti, S., . . . Zuccari, G. (2012).,Enhanced anti-neuroblastoma activity of a fenretinide complexed form after intravenous administration., The Journal of Pharmacy and Pharmacology, 64(2), 228-236. doi:10.1111/j.2042-7158.2011.01403.x [doi]
    Yan, S. B., Peek, V. L., Ajamie, R., Buchanan, S. G., Graff, J. R., Heidler, S. A., . . . Walgren, R. A. (2013).,LY2801653 is an orally bioavailable multi-kinase inhibitor with potent activity against MET, MST1R, and other oncoproteins, and displays anti-tumor activities in mouse xenograft models., Investigational New Drugs, 31(4), 833-844. doi:10.1007/s10637-012-9912-9 [doi]
    Konson, A., Pradeep, S., & Seger, R. (2010).,Phosphomimetic mutants of pigment epithelium-derived factor with enhanced antiangiogenic activity as potent anticancer agents., Cancer Research, 70(15), 6247-6257. doi:10.1158/0008-5472.CAN-10-0434 [doi]
    Portella, L., Vitale, R., De Luca, S., D'Alterio, C., Ierano, C., Napolitano, M., . . . Scala, S. (2013).,Preclinical development of a novel class of CXCR4 antagonist impairing solid tumors growth and metastases., PloS One, 8(9), e74548. doi:10.1371/journal.pone.0074548 [doi]
    Adi Harel, S., Bossel Ben-Moshe, N., Aylon, Y., Bublik, D. R., Moskovits, N., Toperoff, G., . . . Oren, M. (2015).,Reactivation of epigenetically silenced miR-512 and miR-373 sensitizes lung cancer cells to cisplatin and restricts tumor growth., Cell Death and Differentiation, 22(8), 1328-1340. doi:10.1038/cdd.2014.221 [doi]
    Dal Bello, M. G., Alama, A., Barletta, G., Coco, S., Truini, A., Vanni, I., . . . Grossi, F. (2015).,Sequential use of vinorelbine followed by gefitinib enhances the antitumor effect in NSCLC cell lines poorly responsive to reversible EGFR tyrosine kinase inhibitors., International Journal of Cancer.Journal International Du Cancer, doi:10.1002/ijc.29647 [doi]
    Barnea, I., Ben-Yosef, R., Karaush, V., Benhar, I., & Vexler, A. (2013).,Targeting EGFR-positive cancer cells with cetuximab-ZZ-PE38: Results of in vitro and in vivo studies., Head & Neck, 35(8), 1171-1177. doi:10.1002/hed.23093 [doi]
    Barnea, I., Haif, S., Keshet, R., Karaush, V., Lev-Ari, S., Khafif, A., . . . Ben Yosef, R. (2013).,Targeting ErbB-1 and ErbB-4 in irradiated head and neck cancer: Results of in vitro and in vivo studies., Head & Neck, 35(3), 399-407. doi:10.1002/hed.22967 [doi]

    Transplantation

    Aylon, Y., Sarver, A., Tovy, A., Ainbinder, E., & Oren, M. (2014).,Lats2 is critical for the pluripotency and proper differentiation of stem cells., Cell Death and Differentiation, 21(4), 624-633. doi:10.1038/cdd.2013.188 [doi]
    Konson, A., Pradeep, S., & Seger, R. (2010).,Phosphomimetic mutants of pigment epithelium-derived factor with enhanced antiangiogenic activity as potent anticancer agents., Cancer Research, 70(15), 6247-6257. doi:10.1158/0008-5472.CAN-10-0434 [doi]
    Vandenabeele, S. I., DeCock, H., Van Ham, L., Meyer, E., & Daminet, S. (2013).,Study of the behaviour of lesional and nonlesional skin of canine recurrent flank alopecia transplanted to athymic nude mice., Veterinary Dermatology, 24(5), 507-e120. doi:10.1111/vde.12059 [doi]

    Tumor growth

    Bifulco, K., Longanesi-Cattani, I., Liguori, E., Arra, C., Rea, D., Masucci, M. T., . . . Carriero, M. V. (2013).,一个尿激酶receptor-derived肽抑制VEGF-dependent directional migration and vascular sprouting., Molecular Cancer Therapeutics, 12(10), 1981-1993. doi:10.1158/1535-7163.MCT-13-0077 [doi]
    Hardy, B., Raiter, A., Yakimov, M., Vilkin, A., & Niv, Y. (2012).,Colon cancer cells expressing cell surface GRP78 as a marker for reduced tumorigenicity., Cellular Oncology (Dordrecht), 35(5), 345-354. doi:10.1007/s13402-012-0094-4 [doi]
    Ben-Yosef, R., Starr, A., Karaush, V., Loew, V., Lev-Ari, S., Barnea, I., . . . Vexler, A. (2007).,ErbB-4 may control behavior of prostate cancer cells and serve as a target for molecular therapy., The Prostate, 67(8), 871-880. doi:10.1002/pros.20555 [doi]
    Baker, A. M., Bird, D., Welti, J. C., Gourlaouen, M., Lang, G., Murray, G. I., . . . Erler, J. T. (2013).,Lysyl oxidase plays a critical role in endothelial cell stimulation to drive tumor angiogenesis., Cancer Research, 73(2), 583-594. doi:10.1158/0008-5472.CAN-12-2447 [doi]
    Vandsburger, M. H., Radoul, M., Addadi, Y., Mpofu, S., Cohen, B., Eilam, R., & Neeman, M. (2013).,卵巢癌:定量biexponential我先生maging relaxometry reveals the dynamic recruitment of ferritin-expressing fibroblasts to the angiogenic rim of tumors., Radiology, 268(3), 790-801. doi:10.1148/radiol.13122053 [doi]